Experience‐based recommendations for the diagnosis and management of early‐stage nail unit melanoma
- 13 October 2026
- journal article
- recommendation
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
Abstract
Background: Nail unit melanoma (NUM) is a distinct form of melanoma that most often arises from the nail matrix. No recommendations as to the management of nail melanoma, particularly of early‐stage melanoma (in situ, stage IA, IB), exist. Objectives: To provide practical, experience‐based recommendations for the diagnosis, differential diagnosis and management of early‐stage NUM, developed by an international expert panel. Methods: Based on clinical and histopathological experience and an extensive literature search, the authors present recommendations for the management of patients with lesions suspicious for NUM. Results: Clinically, most cases present as a longitudinal pigmented band in an adult nail. It represents 1.5–2.5% of all melanomas in Caucasians but up to 50% in Black patients. Considering that the nail unit surface area accounts for less than 1% of the total body surface, the nail matrix can be regarded as a hotspot for melanoma development. Early diagnosis is critical, as treatment at the in situ or minimally invasive stage is associated with high cure rates. While dermoscopy is a useful diagnostic aid, nail matrix biopsy with histopathology remains the gold standard. Laboratory tests and standard imaging studies are not diagnostic; however, they may assist in surgical planning for advanced cases. Complete surgical excision is the treatment of choice. Wide local excision is recommended for early‐stage disease, with specific margins (6 mm for standard lesions; 10 mm in the presence of the Hutchinson sign). Amputation is generally reserved for thicker tumours (>1 mm). A 10‐year follow‐up period is recommended to monitor for potential recurrence. Conclusions: Early diagnosis and treatment of nail unit melanoma at the in situ or minimally invasive stage (IA/IB) are associated with high cure rates. In contrast, advanced disease with deep invasion or metastasis carries a poor prognosis—therefore, timely recognition and intervention are essential to optimize outcomes.Keywords
This publication has 78 references indexed in Scilit:
- Subungual amelanotic melanoma mimicking persistent onychomycosisAnnales de Dermatologie et de Vénéréologie, 2025
- Surgical excision methods for skin cancer involving the nail unit: A systematic reviewCochrane Evidence Synthesis and Methods, 2023
- High resolution MRI of nail tumors and tumor-like conditionsEuropean Journal of Radiology, 2019
- Assessment of a Predictive Scoring Model for Dermoscopy of Subungual Melanoma In SituJAMA Dermatology, 2018
- Melanoma amelanótico subungueal simulando granuloma telangiectásico. Correlación clínica, histológico y radiológicaActas Dermo-Sifiliograficas, 2017
- In Situ Amelanotic Melanoma of the Nail Unit Mimicking Lichen PlanusArchives of Dermatology, 2010
- Thumb subungual melanoma: Is amputation necessary?Journal of Plastic, Reconstructive & Aesthetic Surgery, 2007
- Presentation, Histopathologic Findings, and Clinical Outcomes in 7 Cases of Melanoma In Situ of the Nail UnitArchives of Dermatology, 2004
- Dermoscopic Examination of Nail PigmentationArchives of Dermatology, 2002
- A role for topical 5‐fluorouracil therapy in melanomaJournal of Surgical Oncology, 1988